Abstract:Introduction Cancer remains a significant health challenge, and nanoparticles (NPs) are promising candidates for cancer treatment due to their unique physicochemical properties and ability to selectively target tumour cells. Two-dimensional (2D) nanomaterials, such as MXenes, have attracted interest due to their electronic structures, optical properties, catalytic abilities, and exceptional physicochemical attributes. MXenes are highly suitable for surface functionalization or modification, and their unique properties make them promising candidates for various applications in the biological field. Silver-based compounds have shown remarkable potential in biomedical fields, with silver oxide (Ag₂O) NPs finding applications in various domains. The fabrication of titanium carbide (Ti₃C₂)-Ag₂O heterostructures has been investigated for their anti-cancer properties by conducting cell viability assays on different cell lines. Aim To synthesize and characterize Ti₃C₂-Ag₂O, and to assess its in vitro anti-cancer activity. Materials and methods Ti₃C₂ synthesis begins by dissolving Ti₃AlC₂ powder in a 50% v/v hydrofluoric (HF) acid solution, allowing the aluminium to be etched away. This process should be conducted with continuous stirring for 24 to 48 hours at ambient temperature. Following this, filter the resulting suspension to eliminate aluminium particles and HF, and subsequently wash the Ti₃C₂ MXene with distilled water until a neutral pH is attained. The MXene should then be dispersed in ethanol, and sonication in deionized (DI) water or an alternative solvent should be employed to achieve exfoliation into monolayer or few-layer MXenes. To prepare Ag₂O NPs, dissolve silver nitrate (AgNO₃) in DI water to create a 0.1 M solution, and concurrently prepare a separate 0.1 M sodium hydroxide (NaOH) solution. Introduce the NaOH solution to the AgNO₃ while stirring until a precipitate is observed. The mixture should then be filtered, washed with distilled water, and the NPs dried at 60°C for 12 hours. To fabricate the MXene-Ag₂O composite, disperse the MXene nanoflakes in a solvent through sonication, incorporate the Ag₂O NPs, and stir the mixture for 24 hours. Finally, centrifuge the resultant mixture to isolate the composite, wash it with solvent, and dry it under vacuum conditions. Results The presence of Ag₂O particles on Ti₃C₂ nanosheets was observed, and the high crystallinity of the compound was confirmed through X-ray diffraction (XRD), energy-dispersive spectroscopy (EDS), and scanning electron microscopy (SEM) analyses. These tests verified that the compound was free of impurities and exhibited anti-cancer properties. Conclusion The synthesis of Ti₃C₂ MXenes and Ag₂O NPs was achieved and confirmed through structural characterization methods, including SEM, XRD, and EDS. SEM provided detailed insights into the morphology and distribution of the nanostructures, while XRD and EDS verified their phase purity and elemental composition. Functionalization strategies were employed to enhance the stability and bioactivity of the nanocomposites. In vitro evaluations demonstrated promising anti-cancer activity, indicating that the Ti₃C₂-Ag₂O composites effectively target and inhibit cancer cell growth.

Noble Hybrid Nanostructures as Efficient Anti-Proliferative Platforms for Human Breast Cancer Cell

Unique Photochemo-Immuno-Nanoplatform Against Orthotopic Xenograft Oral Cancer and Metastatic Syngeneic Breast Cancer.

(Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy

Cerasomes And Bicelles: Hybrid Bilayered Nanostructures With Silica-Like Surface In Cancer Theranostics

Dual-functionalized architecture enables stable and tumor cell-specific SiO2NPs in complex biological fluids

Novel Hybrid Silver-Silica Nanoparticles Synthesized by Modifications of the Sol-Gel Method and Their Theranostic Potential in Cancer

Receptor-Mediated In Vivo Targeting of Breast Cancer Cells with 17α-Ethynylestradiol-Conjugated Silica-Coated Gold Nanoparticles

Charge Regulated pH/NIR Dual Responsive Nanoplatforms Centered on Cuproptosis for Enhanced Cancer Theranostics

A convergent fabrication of pH and redox dual-responsive hybrids of mesoporous silica nanoparticles for the treatment of breast cancer

Biomimetic Boron Nitride Nanoparticles for Targeted Drug Delivery and Enhanced Antitumor Activity

Hybrid ultrasound-activated nanoparticles based on graphene quantum dots for cancer treatment

Nano-Based Theranostic Platforms for Breast Cancer: A Review of Latest Advancements

A Multifunctional Bimetallic Nanoplatform for Synergic Local Hyperthermia and Chemotherapy Targeting HER2-Positive Breast Cancer

Biohybrid nano-platforms manifesting effective cancer therapy: Fabrication, characterization, challenges and clinical perspective

An Effective Nir Laser/Tumor-Microenvironment Co-Responsive Cancer Theranostic Nanoplatform With Multi-Modal Imaging And Therapies

Engineering Mesoporous Silica Nanoparticles for Targeted Alpha Therapy against Breast Cancer

A Transferrin-Conjugated Hollow Nanoplatform for Redox-Controlled and Targeted Chemotherapy of Tumor with Reduced Inflammatory Reactions

Smart Gold-Polymer Nanostructures As Promising Drug Nanocarriers For Dual-Imaging Modality And Synergistic Chemo-Photothermal Therapy in Breast Cancer Cells

Polyvalent Mesoporous Silica Nanoparticle-Aptamer Bioconjugates Target Breast Cancer Cells

Optimizing Titanium Carbide-Silver Oxide Nanostructures for Targeted Cancer Therapy: Synthesis, Functionalization, and In Vitro Evaluations

Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy